James Beshara Fund — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
CB Therapeutics builds a yeast platform for biosynthesis of molecules including psychedelics, cannabis, and alkaloids that are difficult to source through conventional methods.
AI & Machine LearningBiotechDeep TechHealthtechSan Diego, US
Sher Butt(Founder/CEO)inJacob Vogan(Founder)inGuoliang Yu(Executive Officer, Director)Jason (Zhen) Qi(Founder)
BoardBing Zhu(Resignation effective upon this financing.)Alex Wu(Resignation effective upon this financing.)
PartnerJames J Beshara· solo GP
Co-investorsaVentureMetaplanetY Combinator
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.